The association between plasma caspase-3, atherosclerosis, and vascular function in the Dallas Heart Study

Apoptosis

Volumn 13, Issue 10, 2008, Pages 1281-1289

  Matulevicius, Susan ^a   Rohatgi, Anand ^a   Khera, Amit ^a   Das, Sandeep R ^a   Owens, Andrew ^a   Ayers, Colby R ^a   Timaran, Carlos H ^b   Rosero, Eric B ^b   Drazner, Mark H ^a   Peshock, Ronald M ^a   De Lemos, James A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Atherosclerosis; Biological markers; Human; Magnetic resonance imaging; Tomography; X ray computed

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CASPASE 3; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; ELECTRON BEAM TOMOGRAPHY; ETHNIC DIFFERENCE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; UNITED STATES;

ADULT; AGED; ATHEROSCLEROSIS; CASPASE 3; COMPLIANCE; DEMOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; STATISTICS, NONPARAMETRIC; TEXAS;

EID: 51749102133     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-008-0254-1     Document Type: Article

References (56)

1. J Viles-Gonzalez V Fuster J Badimon 2006 Links between inflammation and thrombogenicity in atherosclerosis Curr Mol Med 6 489 499 10.2174/ 156652406778018707
2. H Ait-Oufella K Kinugawa J Zoll 2007 Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice Circulation 115 2168 2177 10.1161/CIRCULATIONAHA.106.662080
3. Y Akishima Y Akasaka Y Ishikawa 2005 Role of macrophage and smooth muscle cell apoptosis in association with oxidized low-density lipoprotein in the atherosclerotic development Mod Pathol 18 365 373 10.1038/modpathol.3800249
4. M Bennett 1999 Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture Cardiovasc Res 41 361 368 10.1016/S0008-6363(98)00212-0
5. M Bennett G Evan S Schwartz 1995 Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques J Clin Invest 95 2266 2274 10.1172/JCI117917
6. P Best D Hasdai G Sangiorgi 1999 Apoptosis. Basic concepts and implications in coronary artery disease Arterioscler Thromb Vasc Biol 19 14 22
7. S Dimmeler C Hermann A Zeiher 1998 Apoptosis of endothelial cells. Contribution to the pathophysiology of atherosclerosis? Eur Cytokine Netw 9 697 698
8. G Norata L Tonti P Roma A Catapano 2002 Apoptosis and proliferation of endothelial cells in early atherosclerotic lesions: possible role of oxidised LDL Nutr Metab Cardiovasc Dis 12 297 305
9. M Krajewska H-G Wang S Krajewski 1997 Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease Cancer Res 57 1605 1613
10. F Chen P Eriksson T Kimura I Herzfeld G Valen 2005 Apoptosis and angiogenesis are induced in the unstable coronary atherosclerotic plaque Coron Artery Dis 16 191 197 10.1097/00019501-200505000-00009
11. T Littlewood M Bennett 2003 Apoptotic cell death in atherosclerosis Curr Opin Lipidol 14 469 475 10.1097/00041433-200310000-00007
12. JL Reeve AM Duffy T O'Brien A Samali 2005 Don't lose heart-therapeutic value of apoptosis prevention in the treatment of cardiovascular disease J Cell Mol Med 9 609 622 10.1111/j.1582-4934.2005.tb00492.x
13. Cryns V, Yuan J (1998) Proteases to die for. Genes Dev 12:1551-1570. Erratum appears in Genes Dev 13(3):371 (1999). doi: 10.1101/gad.12.11.1551
14. T Nhan W Liles A Chait J Fallon S Schwartz 2003 The p17 cleaved form of caspase-3 is present within viable macrophages in vitro and in atherosclerotic plaque Arterioscler Thromb Vasc Biol 23 1276 1282 10.1161/01.ATV.0000078602. 54433.07
15. J Martin-Ventura L Blanco-Colio B Munoz-Garcia 2004 NF-kappaB activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: potential implication in plaque instability Stroke 35 458 463 10.1161/01.STR.0000114876.51656.7A
16. C Prunet J Petit A Ecarnot-Laubriet 2006 High circulating levels of 7beta- and 7alpha-hydroxycholesterol and presence of apoptotic and oxidative markers in arterial lesions of normocholesterolemic atherosclerotic patients undergoing endarterectomy Pathol Biol (Paris) 54 22 32 10.1016/j.patbio.2004.11. 002
17. R Victor R Haley D Willett 2004 The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health Am J Cardiol 93 1473 1480 10.1016/j.amjcard.2004.02.058
18. T Jain R Peshock D McGuire 2004 African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study J Am Coll Cardiol 44 1011 1017 10.1016/j.jacc.2004.05.069
19. M Drazner D Dries R Peshock 2005 Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study Hypertension 46 124 129 10.1161/01.HYP.0000169972.96201.8e See comment
20. E Rivers J Kruse G Jacobsen 2007 The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock Crit Care Med 35 2016 2024 10.1097/01.CCM.0000281637.08984.6E See comment
21. A Khera D McGuire S Murphy 2005 Race and gender differences in C-reactive protein levels J Am Coll Cardiol 46 464 469 10.1016/j.jacc.2005.04.051
22. S Abdullah A Khera S Das 2005 Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of N-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study) Am J Cardiol 96 1284 1289 10.1016/j.amjcard.2005.06.073
23. JA de Lemos DA Morrow JH Bentley 2001 The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med 345 1014 1021 10.1056/NEJMoa011053
24. R Deo A Khera D McGuire 2004 Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis J Am Coll Cardiol 44 1812 1818 10.1016/j.jacc.2004. 07.047 Comment
25. M Abedin T Omland T Ueland 2007 Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study) Am J Cardiol 99 513 518 10.1016/j.amjcard.2006.08.064
26. T Wallace S Abdullah M Drazner 2006 Prevalence and determinants of troponin T elevation in the general population Circulation 113 1958 1965 10.1161/CIRCULATIONAHA.105.609974
27. R Guerra Z Yu S Marcovina R Peshock J Cohen H Hobbs 2005 Lipoprotein(a) and apolipoprotein(a) isoforms: no association with coronary artery calcification in the Dallas Heart Study Circulation 111 1471 1479 10.1161/01.CIR.0000159263.50305.BD
28. J de Lemos A Zirlik U Schonbeck 2005 Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study Arterioscler Thromb Vasc Biol 25 2192 2196 10.1161/01.ATV.0000182904.08513.60
29. M Abedin T Omland T Ueland 2007 Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study) Am J Cardiol 99 513 518 10.1016/j.amjcard.2006.08.064 See comment
30. C Heeschen S Dimmeler C Hamm 2003 Soluble CD40 ligand in acute coronary syndromes N Engl J Med 348 1104 1111 10.1056/NEJMoa022600
31. P Ridker N Rifai L Rose J Buring N Cook 2002 Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 1557 1565 10.1056/NEJMoa021993 See comment
32. M Hebert M Masse N Vigneault I Sirois S Troyanov F Madore 2001 Soluble Fas is a marker of coronary artery disease in patients with end-stage renal disease Am J Kidney Dis 38 1271 1276 10.1053/ajkd.2001.29224
33. M Masse M Hebert S Troyanov N Vigneault I Sirois F Madore 2002 Soluble Fas is a marker of peripheral arterial occlusive disease in haemodialysis patients Nephrol Dial Transplant 17 485 491 10.1093/ndt/17.3.485
34. S Troyanov M Hebert M Masse N Vigneault I Sirois F Madore 2003 Soluble Fas: a novel predictor of atherosclerosis in dialysis patients Am J Kidney Dis 41 1043 1051 10.1016/S0272-6386(03)00202-6
35. T Okura S Watanabe Y Jiang 2002 Soluble Fas ligand and atherosclerosis in hypertensive patients J Hypertens 20 895 898 10.1097/00004872-200205000-00024 See comment
36. I van der Meer H Oei A Hofman H Pols F de Jong J Witteman 2006 Soluble Fas, a mediator of apoptosis, C-reactive protein, and coronary and extracoronary atherosclerosis. The Rotterdam Coronary Calcification Study Atherosclerosis 189 464 469 10.1016/j.atherosclerosis.2006.01.004
37. J Boyle P Weissberg M Bennett 2003 Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms Arterioscler Thromb Vasc Biol 23 1553 1558 10.1161/01.ATV. 0000086961.44581.B7
38. Y Tintut J Patel F Parhami LL Demer 2000 Tumor necrosis factor-α promotes in vitro calcification of vascular cells via the cAMP pathway Circulation 102 2636 2642
39. M Reilly A Rohatgi K McMahon 2007 Plasma cytokines, metabolic syndrome, and atherosclerosis in humans J Investig Med 55 26 35 10.2310/6650.2007.06013
40. MK Hong J Vossoughi GS Mintz 1997 Altered compliance and residual strain precede angiographically detectable early atherosclerosis in low-density lipoprotein receptor deficiency Arterioscler Thromb Vasc Biol 17 2209 2217
41. KM Dalessandri H Bogren BM Lantz H Tsukamoto S Bjorkerud J Brock 1990 Aortic compliance in hypercholesterolemic Watanabe rabbits compared to normal New Zealand controls J Invest Surg 3 245 251 10.3109/08941939009140354
42. DJ Farrar MG Bond WA Riley JK Sawyer 1991 Anatomic correlates of aortic pulse wave velocity and carotid artery elasticity during atherosclerosis progression and regression in monkeys Circulation 83 1754 1763
43. SS Franklin SA Khan ND Wong MG Larson D Levy 1999 Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham Heart Study Circulation 100 354 360
44. ED Lehmann KD Hopkins RG Gosling 1993 Aortic compliance measurements using Doppler ultrasound: in vivo biochemical correlates Ultrasound Med Biol 19 683 710 10.1016/0301-5629(93)90087-5
45. A Nigam GF Mitchell J Lambert JC Tardif 2003 Relation between conduit vessel stiffness (assessed by tonometry) and endothelial function (assessed by flow-mediated dilatation) in patients with and without coronary heart disease Am J Cardiol 92 395 399 10.1016/S0002-9149(03)00656-8
46. MJ Budoff LJ Shaw ST Liu 2007 Long-term prognosis associated with coronary calcification: observations from a registry of 25, 253 patients J Am Coll Cardiol 49 1860 1870 10.1016/j.jacc.2006.10.079 See comment
47. A Trion A van der Laarse 2004 Vascular smooth muscle cells and calcification in atherosclerosis Am Heart J 147 808 814 10.1016/j.ahj.2003.10. 047
48. D Proudfoot J Skepper L Hegyi M Bennett C Shanahan P Weissberg 2000 Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies Circ Res 87 1055 1062
49. M Clarke T Littlewood N Figg 2008 Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration Circ Res 102 1529 1538 10.1161/CIRCRESAHA.108.175976
50. MM Kockx GRY De Meyer J Muhring W Jacob H Bult AG Herman 1998 Apoptosis and related proteins in different stages of human atherosclerotic plaques Circulation 97 2307 2315
51. A Samali B Zhivotovsky DP Jones S Orrenius 1998 Detection of pro-caspase-3 in cytosol and mitochondria of various tissues FEBS Lett 431 167 169 10.1016/S0014-5793(98)00740-6
52. L Balsam G Mokhtari S Jones 2005 Early inhibition of caspase-3 activity lessens the development of graft coronary artery disease J Heart Lung Transplant 24 827 832 10.1016/j.healun.2004.05.015
53. M Sarai D Hartung A Petrov 2007 Broad and specific caspase inhibitor-induced acute repression of apoptosis in atherosclerotic lesions evaluated by radiolabeled annexin A5 imaging J Am Coll Cardiol 50 2305 2312 10.1016/j.jacc.2007.08.044
54. J Viles-Gonzalez V Fuster R Corti 2005 Atherosclerosis regression and TP receptor inhibition: effect of S18886 on plaque size and composition-a magnetic resonance imaging study Eur Heart J 26 1557 1561 10.1093/eurheartj/ehi175
55. D Hartung M Sarai A Petrov 2005 Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy J Nucl Med 46 2051 2056
56. E Moran D Agrawal 2007 Increased expression of inhibitor of apoptosis proteins in atherosclerotic plaques of symptomatic patients with carotid stenosis Exp Mol Pathol 83 11 16 10.1016/j.yexmp.2006.09.006